Magda Aguiar1, Lazaros Andronis1, Miranda Pallan2, Wolfgang Högler3,4, Emma Frew1. 1. Health Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK. 2. Department of Public Health, Epidemiology and Biotatistics, Institute of Applied Health Research, University of Birmingham, Birmingham, UK. 3. Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK. 4. Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Abstract
Background: Vitamin D deficiency (VDD) is a public health concern worldwide. If untreated, it can lead to reduced quality of life and escalated costs brought about by ill-health. Preventive programmes to improve population vitamin D status exist but little is known about their cost-effectiveness. This information is vital so that decision-makers adopt efficient strategies and optimise use of public resources. Aims: Systematically review and critically appraise economic evaluations of population strategies to prevent VDD. Methods: The databases reviewed were MEDLINE, EMBASE, Econlit, NHS EED, CEA, and RepEc. All full economic evaluations of VDD prevention strategies were included. Interventions considered were food fortification, supplementation and public health campaigns. Data extracted included type of evaluation, population, setting, measure of benefit and main results. Results: Of the 2492 records screened, 14 studies were included. The majority of studies focused on supplementation within at-risk groups with the primary objective of either preventing fractures or falls in older adults. There was insufficient economic evidence to draw conclusions about the cost-effectiveness of population strategies. No study was identified that offered a direct comparison of the two main alternative population strategies: food fortification vs. supplementation. Conclusions: Whilst there is a growing body of evidence on the cost-effectiveness of micro nutrient programmes, there is a paucity of data on vitamin D fortification and how fortification programmes compare to population supplementation programmes. We highlight research gaps, and offer suggestions of what is required to undertake population-based cost-effectiveness analysis.
Background: Vitamin D deficiency (VDD) is a public health concern worldwide. If untreated, it can lead to reduced quality of life and escalated costs brought about by ill-health. Preventive programmes to improve population vitamin D status exist but little is known about their cost-effectiveness. This information is vital so that decision-makers adopt efficient strategies and optimise use of public resources. Aims: Systematically review and critically appraise economic evaluations of population strategies to prevent VDD. Methods: The databases reviewed were MEDLINE, EMBASE, Econlit, NHS EED, CEA, and RepEc. All full economic evaluations of VDD prevention strategies were included. Interventions considered were food fortification, supplementation and public health campaigns. Data extracted included type of evaluation, population, setting, measure of benefit and main results. Results: Of the 2492 records screened, 14 studies were included. The majority of studies focused on supplementation within at-risk groups with the primary objective of either preventing fractures or falls in older adults. There was insufficient economic evidence to draw conclusions about the cost-effectiveness of population strategies. No study was identified that offered a direct comparison of the two main alternative population strategies: food fortification vs. supplementation. Conclusions: Whilst there is a growing body of evidence on the cost-effectiveness of micro nutrient programmes, there is a paucity of data on vitamin D fortification and how fortification programmes compare to population supplementation programmes. We highlight research gaps, and offer suggestions of what is required to undertake population-based cost-effectiveness analysis.
Authors: Stefan Pilz; Winfried März; Kevin D Cashman; Mairead E Kiely; Susan J Whiting; Michael F Holick; William B Grant; Pawel Pludowski; Mickael Hiligsmann; Christian Trummer; Verena Schwetz; Elisabeth Lerchbaum; Marlene Pandis; Andreas Tomaschitz; Martin R Grübler; Martin Gaksch; Nicolas Verheyen; Bruce W Hollis; Lars Rejnmark; Spyridon N Karras; Andreas Hahn; Heike A Bischoff-Ferrari; Jörg Reichrath; Rolf Jorde; Ibrahim Elmadfa; Reinhold Vieth; Robert Scragg; Mona S Calvo; Natasja M van Schoor; Roger Bouillon; Paul Lips; Suvi T Itkonen; Adrian R Martineau; Christel Lamberg-Allardt; Armin Zittermann Journal: Front Endocrinol (Lausanne) Date: 2018-07-17 Impact factor: 5.555
Authors: Francesca L Crowe; Kate Jolly; Christine MacArthur; Semira Manaseki-Holland; Neil Gittoes; Martin Hewison; Robert Scragg; Krishnarajah Nirantharakumar Journal: BMJ Open Date: 2019-06-04 Impact factor: 2.692
Authors: Daniel E Roth; Steven A Abrams; John Aloia; Gilles Bergeron; Megan W Bourassa; Kenneth H Brown; Mona S Calvo; Kevin D Cashman; Gerald Combs; Luz María De-Regil; Maria Elena Jefferds; Kerry S Jones; Hallie Kapner; Adrian R Martineau; Lynnette M Neufeld; Rosemary L Schleicher; Tom D Thacher; Susan J Whiting Journal: Ann N Y Acad Sci Date: 2018-09-18 Impact factor: 5.691